Idarubicin - Product Introduction

Definition: Idarubicin is an anthracycline antibiotic and chemotherapeutic agent, derived from daunorubicin. It is used primarily for the treatment of various cancers, particularly hematological malignancies like leukemia.

Functions:

· Intercalates into DNA, inhibiting DNA and RNA synthesis, leading to cell death.

· Induces apoptosis in cancer cells by disrupting cellular replication and causing DNA damage.

· Known for its potent cytotoxic effects, especially against rapidly dividing cancer cells.

Applications:

· Pharmaceutical Industry: Used in injectable formulations for the treatment of acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL), and other hematological cancers.

· Healthcare: Administered in chemotherapy regimens for leukemia and other cancers, often in combination with other anticancer drugs to enhance efficacy.

· Research: Studied for its effectiveness in combination therapies and its potential to treat resistant cancer strains.